Praziquantel paediatric formulation - Pediatric Praziquantel Consortium

Drug Profile

Praziquantel paediatric formulation - Pediatric Praziquantel Consortium

Alternative Names: L-praziquantel; L-PZQ; L-PZQ ODT; MSC-1028703; MSC-1028703A; MSC-2499550A; PZQ ODT; Rac-PZQ ODT; Racemate PZQ ODT

Latest Information Update: 28 May 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pediatric Praziquantel Consortium
  • Class 3-ring heterocyclic compounds; Anthelmintics; Cyclohexanes; Isoquinolines; Pyrazines; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Schistosomiasis

Most Recent Events

  • 28 May 2018 No recent reports of development identified for phase-I development in Schistosomiasis(In children, In volunteers) in Tanzania (PO, Fast dissolve)
  • 22 May 2018 The Kenya Medical Research Institute and the Université Félix Houphouët-Boigny plan a phase III trial, co-funded by the Consortium, the European & Developing Countries Clinical Trials Partnership and the Global Health Innovative Technology Fund, for Schistosomiasis (In children, In infants) in West Africa in 2018
  • 22 May 2018 The Pediatric Praziquantel Consortium intends to submit a Marketing Authorization Application in 2020, and launch the product in the first endemic countries in Africa in 2021
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top